methylprednisolone has been researched along with s 1743 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, PL; Geevasinga, N; Kairaitis, L; Rangan, GK | 1 |
| Bartoli, F; Blagojevic, J; Bruni, C; Cometi, L; Fiori, G; Furst, DE; Galluccio, F; Matucci Cerinic, M; Tofani, L | 1 |
2 other study(ies) available for methylprednisolone and s 1743
| Article | Year |
|---|---|
Acute interstitial nephritis secondary to esomeprazole.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Ulcer Agents; Dyspepsia; Esomeprazole; Female; Hematuria; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Nephritis, Interstitial; Prednisone; Proton Pump Inhibitors; Vomiting | 2005 |
Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
Topics: Acetaminophen; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chlorpheniramine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Female; Humans; Hydrocortisone; Hydroxyzine; Infliximab; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Premedication; Ranitidine; Retrospective Studies; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |